help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tu, H. M.
Right arrow Articles by Lechan, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tu, H. M.
Right arrow Articles by Lechan, R. M.
Endocrinology Vol. 138, No. 8 3359-3368
Copyright © 1997 by The Endocrine Society


ARTICLES

Regional Distribution of Type 2 Thyroxine Deiodinase Messenger Ribonucleic Acid in Rat Hypothalamus and Pituitary and Its Regulation by Thyroid Hormone1

Helen M. Tu2, Sung-Woo Kim2, Domenico Salvatore, Tibor Bartha, Gabor Legradi, P. Reed Larsen and Ronald M. Lechan

Tupper Research Institute and Department of Medicine, Division of Endocrinology, Diabetes, Metabolism and Molecular Medicine (G.L., R.M.L.), New England Medical Center; Thyroid Division, Department of Medicine, Brigham and Womens Hospital and Harvard Medical School (H.M.T., S-W.K., D.S., T.B., P.R.L.); and Department of Neuroscience, Tufts University School of Medicine (R.M.L.), Boston, Massachusetts 02111

Address all correspondence and requests for reprints to: Ronald M. Lechan, Division of Endocrinology, Box 268, New England Medical Center, 750 Washington Street, Boston, Massachusetts 02111.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
To identify the specific locations of type 2 deiodinase (D2) messenger RNA (mRNA) in the hypothalamus and pituitary gland and determine its regulation by thyroid hormone, we performed in situ hybridization histochemistry, Northern analysis, and quantitative RT-PCR in euthyroid, hypothyroid, and hyperthyroid rats. By in situ hybridization histochemistry, silver grains were concentrated over ependymal cells lining the floor and infralateral walls of the third ventricle extending from the rostral tip of the median eminence (ME) to the infundibular recess, surrounding blood vessels in the arcuate nucleus (ARC), and in the ME adjacent to the portal vessels and overlying the tuberoinfundibular sulci. Silver grains also accumulated over distinct cells in the midportion of the anterior pituitary. In hypothyroid animals, an increase in signal intensity was observed in the caudal hypothalamus, and a marked increase in the number of positive cells occurred in the anterior pituitary. Microdissection of the hypothalamus for Northern and PCR analysis established the authenticity of D2 mRNA in the caudal hypothalamus, and confirmed that the majority of D2 mRNA is concentrated in this region. The distribution of D2 mRNA suggests its expression in specialized ependymal cells, termed tanycytes, originating from the third ventricle. Thus, the tanycyte is the source of the high D2 activity previously found in the ARC-ME region of the hypothalamus. The results indicate that tanycytes may have a previously unrecognized integral role in feedback regulation of TSH secretion by T4.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE GENERATION of T3 from T4 is an essential step for thyroid hormone activation. Although two, separate deiodinating enzymes, types 1 and 2 deiodinase (D1 and D2), can catalyze the conversion of T4 to T3, D1 predominates in peripheral tissues such as the liver and kidney, whereas D2 predominates in the brain (1). Both deiodinases, however, are present in the anterior pituitary (AP) gland (2). Greater than 75% of nuclear T3 in the brain is derived from the conversion of T4 to T3 by D2 within the central nervous system (CNS) (3). An increase in D2 activity when circulating T4 falls helps compensate for the hypothyroxinemia of iodine deficiency (4) or hypothyroidism (5). Enzymatic D2 activity has been demonstrated in several regions of the brain including the cerebral cortex (CC) and cerebellum, and Riskind et al. (6) have provided evidence for high D2 activity in the arcuate nucleus-median eminence (ARC-ME) region in both euthyroid and hypothyroid rats. The precise distribution of D2 in the CNS and the cells of origin, however, are not known.

With the recent molecular characterization of the rat and human D2 (7, 8), new probes for the anatomical and physiological study of D2 in the brain have become available. By Northern blot hybridization, Croteau et al. (7) reported the presence of D2 messenger RNA (mRNA) in several regions of the rat and human brain, although they did not analyze the hypothalamus. We used D2 mRNA probes, therefore, to identify the specific locations of D2 transcripts in the rat hypothalamus and pituitary gland by in situ hybridization histochemistry, Northern blots, and quantitative competitive PCR.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Adult, male Sprague-Dawley rats (Taconic Farms, Germantown, NY; Charles River, Worcester, MA; or Zivic Miller Laboratory, Zelienople, PA) weighing between 125 and 200 g were acclimated to a 12 h light, 12 h dark cycle (lights between 0600–1800 h) and controlled temperature (22 ± 1 C). Rat chow and tap water were provided ad libitum. All experimental protocols were reviewed and approved by the animal welfare committee at the Brigham and Womens Hospital and New England Medical Center. Animals were made hypothyroid by the addition of 0.02% methimazole to their drinking water for 3 weeks or by thyroidectomy by the supplier with parathyroid reimplantation and were killed 10 days following surgery; another group was made hyperthyroid by daily ip injections of T3, 50 µg/100 g BW every other day for 8 days; and normal, euthyroid animals of the same age and supplier were used as controls.

In situ hybridization histochemistry
For in situ hybridization histochemistry, five animals in each of the hypothyroid and control groups were weighed, overdosed with pentobarbital, and perfused through the ascending aorta with 0.01 M PBS, pH 7.2, containing 15,000 U/liter heparin sulfate for 30–60 sec, followed by 4% paraformaldehyde in PBS for 15 min. Venous blood was collected from the inferior vena cava for measurement of T4 and T3. Brains were removed, postfixed by immersion in the same fixative for 6 h, and placed in 20% sucrose in PBS at 4 C overnight. Coronal tissue sections (18 µm) through the forebrain and pituitary gland were obtained on a cryostat (Reichert-Jung 2800 Frigocut-E, Leica, Deerfield, IL) and adhered to Superfrost Plus glass slides (Fisher Scientific Co., Pittsburgh, PA). The sections were desiccated overnight by heating at 42 C and stored at -80 C until prepared for in situ hybridization histochemistry.

The hybridization protocol was based on methods previously reported from our laboratories (9, 10). Tissue sections were hybridized with a single stranded [35S]uridine triphosphate-labeled complementary RNA probe generated from a linearized 1.4-kilobase (kb) rat D2 (rD2) complementary DNA (cDNA) in Bluescript SK vector (pBS-SK) kindly provided by Drs. St. Germain and Galton (7). The plasmid was linearized with BamHI (at position 421) and transcribed with T7 polymerase. As a control, we linearized the same plasmid with XhoI and transcribed sense RNA with T3 polymerase. The rat D2 antisense probe contained the entire 788 nt coding region and approximately 160 nt 5' untranslated region. The same sequences were included in the sense RNA. Hybridization was performed under plastic coverslips in buffer containing 50% formamide, a 2-fold concentration of standard sodium citrate (2x SSC), 10% dextran sulfate, 0.25% BSA, 0.25% Ficoll 400, 0.25% polyvinylpyrolidone 360, 250 mM Tris (pH 7.5), 0.5% sodium pyrophosphate, 0.5% SDS, 250 mg/ml denatured salmon sperm DNA, and 6 x 105 cpm of the radiolabeled probe for 16 h at 55 C. Slides were dipped into Kodak NTB2 autoradiography emulsion (Eastman Kodak, Rochester, NY), and the autoradiograms developed after 6 days of exposure at 4 C. After being cleared in graded solutions of ethanol and Histosol (National Diagnostics, Atlanta, GA), the sections were coverslipped in Histomount (National Diagnostics) and the autoradiograms visualized and photographed under dark-field illumination with a Zeiss photomicroscope III (Carl Zeiss Inc., Thornwood, NY) or Olympus BX60 (Olympus America Inc., Lake Success, NY) binocular microscope.

Northern analysis
Seven euthyroid animals were deeply anesthesized by pentobarbital and decapitated. Trunk blood was collected for RIA of T3 and T4. The brain was rapidly removed from the calvarium, and the region of the basal hypothalamus containing the ARC-ME was removed by gross dissection under a binocular microscope using iridectomy scissors and then snap frozen. Landmarks for dissection included the anterior, posterior, and lateral boundaries of the ME. The pituitary was removed from the sella turcica by disrupting the diaphragma with a 30-gauge needle and similarly frozen. RNA was isolated according to the single-step RNA isolation method of Chomczynski (11), using TriZoL (Gibco, Gaithersburg, MD). Thirty micrograms of total RNA was electrophoresed through 1% agarose/1.85% formaldehyde/2 µg ethidium bromide/1 x 3-(N-morpholino)-propanesulfonic acid gel at room temperature. RNA was transferred by capillary action with 10x SSC according to the manufacturer’s recommendations (Genescreen Plus, NEN Life Sciences, Boston, MA), and completion of transfer was verified by the presence of all of the 0.24–9.5-kb RNA molecular weight marker bands (BRL, Gaithersburg, MD) as well as the 28S and 18S ribosomal RNA. RNA was fixed to the nylon membrane by UV cross-linking with the Stratalinker (Stratagene, La Jolla, CA).

Northerns were hybridized for D2 mRNA under high stringency conditions (40% formamide/2x Denhardt’s reagent/0.64 M NaCl/40 mM PO4, pH 5.6/0.8 mM EDTA pH 7.4/7% dextran sulfate/1.6% SDS/80 µg/ml denatured sonicated thymus DNA at 42 C). D2 probed Genescreen Plus filters were washed sequentially three times with 2x SSC/0.1% SDS at RT, once with 2x SSC/0.1% SDS at 42 C, and once with 0.5x SSC/0.1% SDS at 42 C. Blots were autoradiographed for 1 week with an intensifying screen at -80 C.

A cDNA probe was made by random priming of template DNA with [{alpha}32P]deoxycytidine triphosphate. A 0.95-kb fragment of rD2 in pBS-SK containing small portions of the 5' and 3' flanking regions and 788 nt of coding region (kindly provided by D. St. Germain and V.A. Galton) (7) was gel purified for the D2 template. Quantitation of hybrization signals was done with a scanning densitometer and Molecular Dynamics software v.3.1 (Sunnyvale, CA).

Quantitative RT-PCR
For quantitative RT-PCR, two groups of animals were studied. In one experiment, six animals in each of three groups (control, hypothyroid, and hyperthyroid) were weighed, overdosed with pentobarbital or anesthetized with CO2, and decapitated with a rodent guillotine. Trunk blood was obtained for RIA of T4 and T3, and the brain rapidly removed from the calvarium for dissection. A region of the hypothalamus that included the entire ME, stalk, and ARC was dissected from the base of the brain with iridectomy scissors as described above (ARC-ME). Tissue fragments from two animals were pooled in a sterile Eppendorf tube and snap frozen. The remainder of the hypothalamus (referred to as residual hypothalamus or RH) was removed with iridectomy scissors as a cone using the optic chiasm as the anterior boundary, medial mammillary body as the posterior boundary, and lateral edge of the hypothalamus at the border of the pyriform lobes as the lateral boundaries and immediately frozen with liquid nitrogen in a piece of aluminum foil.

To obtain tissue fragments of the hypothalamus that corresponded more closely to the distribution of D2 mRNA seen by in situ hybridization histochemistry, a separate experiment was performed in which the forebrains of three euthyroid and three hypothyroid animals were snap frozen in hexanes with dry ice and sectioned coronally with stainless steel razor blades on a specially designed template to obtain three regions of the hypothalamus, each approximately 1.5 mm thick; the preoptic region, a midregion of the hypothalamus defined by the rostral-caudal extent of the optic chiasm, and a caudal region containing the full rostral-caudal extent of the ME. The sections were transferred to glass slides and kept frozen on a slab of dry ice. The caudal region of the hypothalamus was further dissected with a microscalpel to obtain a fragment of tissue containing the entire ME and stalk, the region of the third ventricle extending from the rostral border of the ME to the infundibular recess, ARC, dorsomedial nucleus, and medial portions of the ventromedial nucleus using the fornix as lateral boundaries, and the top of the third ventricle as a dorsal boundary (ARC-ME). For comparison with the ARC-ME region, other portions of the hypothalamus were sampled by punching the tissue with 1.0-mm hollow needles; the paraventricular nucleus (PVN), from the midregion of the hypothalamus at the dorsal limits of the third ventricle and the lateral hypothalamus (LH), from the mid- and caudal regions of the hypothalamus. Punches from the CC were also obtained. The tissue fragments from each animal were expelled into Eppendorf tubes and snap frozen. Pituitary glands from the three euthyroid and three hypothyroid rats were removed from the sella turcica, the AP dissected free from the neural lobe/intermediate lobe (NL), and frozen individually.

RNA was isolated from the AP, NL, and each of the microdissected regions of the brain in the eu-, hypo-, and hyperthyroid rats using TriZoL reagent. Tissues from two identically treated animals were pooled for each sample in the first study, and in the second, isolated fragments from individual rats were used as described above. RNA from AP and the remainder of the hypothalamus from which the ARC-ME had been removed was adjusted to 1 µg/µl in RNase-free water (diethylprocarbonate-H2O). For the RNA isolation from NL, ARC-ME, PVN, and CC, 5 µg transfer RNA carrier was added to the TriZoL, and total RNA was isolated. The total RNA was dissolved in 10 µl diethylprocarbonate-H2O. For the 20-µl RT reaction, 1 µl RNA was mixed with 0.25 µM of either rD2-specific antisense primer (nt 1381–1358) or rat cyclophilin (rCyc)-specific antisense primer (nt 557–534), 0.5 mM deoxynucleotide triphosphates, 0.6 U/µl RNasin (Promega, Madison, WI), 10 mM deoxynucleotide triphosphate, and 10 U/µl Moloney Murine leukemia virus reverse transcriptase (Life Technologies, Gaithersburg, MD) and incubated 90 min at 37 C. Then, the reaction mixture was heated to 95 C for 5 min.

For the competitive PCR, the rat D2 partial cDNA clone 5–1 in pBS-SK (see above) was used to prepare a mutant D2 plasmid (7). This clone contains a portion of the 5' untranslated region and the entire coding region, which are located in the extreme 5' portion of the mRNA based on homology with the human D2 gene (our unpublished observations). To construct a mutant rD2 plasmid, a 156-bp fragment between two BsaAI restriction sites (nt 688–843) within the coding region was deleted and the plasmid re-ligated. The sense primer for the PCR (D2-S) was nt 545 GAGTGCACAGGAGACTGACTG 645 and the antisense primer (D2-A) was nt 1350 CTTCTCCAGCCAACTTCGGAC 1330 from the EcoRI 5' cloning site. To construct a rCyc mutant plasmid, a cDNA clone of the rat mRNA encoding Cyc (p1B15) (12) was used in which a 126-bp fragment between two NcoI restriction sites (nt 339–464) within the coding region was deleted and the plasmid re-ligated. The sense primer (Cyc-S) was 7 AGACGCCGCTGTCTCTTTTCG 27, and the antisense primer (Cyc-A) was 527 CCACAGTCGGAGATGGTGATC 507 from the transcription start site of the clone p1B15.

For quantitation of the RT product, competitive PCR was performed as previously reported (13) with minor modifications. For the D2 amplification in a 40-µl PCR reaction, 4 µl RT product was mixed with 2 mM MgSO4, 10 mM KCl, 20 mM Tris-HCl (pH 8.8), 10 mM (NH4)2SO4, 0.1% Triton X-100, 1.4 µM sense and antisense primers (D2-S and D2-A), 100 nM deoxynucleotide triphosphates, 75 nCi/µl P32-[{alpha}]deoxycytidine triphosphate, 0.3125–2.5 pg mutant rD2 containing plasmid (mrD2), and 12.5 mU/µl Vent DNA polymerase (New England Biolabs, Beverly, MA). Subsequently, 30–35 cycles of PCR amplification were carried out with denaturation at 95 C for 1 min, annealing at 61 C for 1 min, and extension at 76 C for 1.5 min after an initial 5 min denaturation at 95 C using a PTC-100 Programmable Thermal Controller (MJ Research, Watertown, MA). For the calibration, a standard curve was plotted by performing PCR with serial dilutions of the wild-type D2 or Cyc plasmid. These diluted plasmids were amplified at the same time as the experimental samples. After the D2 amplification, the D2 PCR product was kept at -20 C.

Subsequently, Cyc cDNA was amplified for the same samples. For the amplification of Cyc, Cyc-S and Cyc-A primers, and mutant rCyc plasmid were used for performing 21 cycles of PCR. After amplification of both the D2 and Cyc, 20 µl D2 and 20 µl Cyc PCR product were mixed with 10 µl 6x gel loading buffer. Forty microliters from each mix was loaded on a 4% polyacrylamide gel and run at 150 V for 1–2 h. The gel was dried and exposed to a phosphoimager for 10–20 h. The ratio of wild-type to mutant bands was then determined for standards and unknowns. For quantitation, the relative D2 density ratio was plotted against the serially diluted concentrations of the standard D2 plasmids. The curve was virtually linear but was fit to a second-order polynomial equation. This was used to determine the quantity of D2 cDNA present in the RT reaction. The same process was performed to quantitate Cyc mRNA. The ratio of D2 to Cyc mRNA was then calculated. Dilutions of the RT product gave wt/mt density ratios parallel to the standard curve for both D2 and Cyc. Reproducibility was measured by quantitating D2 in the same mRNA sample from AP in duplicate PCR runs from three different RT reactions. The estimated mean D2 content for this pituitary was 0.63 ± 0.058 (SD) pg (n = 6).

Hormone measurements
Plasma T4 and T3 concentrations were measured by RIA in the NIH General Clinical Research Center core laboratory of the Brigham and Women’s Hospital.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Alterations in circulating thyroid hormone levels induced by methimazole or thyroidectomy (hypothyroid group) or the administration of T3 (hyperthyroid group) were established by RIA. Serum T4 concentrations in euthyroid rats were 30–80 nmol/liter and were less than 12 nmol/liter in hypothyroid or T3-treated rats. Serum T3 concentrations were more than 13 nmol/liter 6 h after the fourth injection in T3-injected rats. Hypothyroid animals were also distinguished from the other groups by a significant reduction in BW [198 ± 3 g (SE) for hypothyroid, 266 ± 3 g for euthyroid, and 247 ± 10 g for T3-treated rats).

By in situ hybridization histochemistry, silver grains representing D2 mRNA appeared to be distributed widely but in low abundance throughout the forebrain and were only marginally greater than background hybridization as judged by the appearance of control sections using the D2 sense probe. With the exception of the hypothalamus and pituitary gland, no apparent differences in intensity or distribution of hybridization signal were noted in the hypothyroid animals. Within the hypothalamus, hybridization was distinct, highly concentrated between the rostral pole of the ME and the infundibular recess, and more apparent in hypothyroid animals (Figs. 1Go and 2Go). In this region, silver grains were localized over ependymal cells in the floor of the third ventricle, especially in its lateral portions, and extended onto its infralateral walls (Figs. 1Go, B-F and 2). Hybridization ceased abruptly approximately one half to two thirds up the third ventricular wall (Fig. 1Go, B-E) and was absent from the roof of the infundibular recess (Fig. 1FGo). Hybridization above background was conspicuously absent from other regions of the third ventricle rostral to the anterior pole of the ME including the supraoptic recess, as well as from the cerebral aqueduct and lateral ventricles (Fig. 1AGo).



View larger version (68K):
[in this window]
[in a new window]
 
Figure 1. Rostral-caudal distribution of D2 mRNA in tuberal region of hypothalamus in hypothyroid animals (dark-field illumination). In the most rostral section (A), hybridization is present in the external zone of ME but is absent from walls of third ventricle (III). In more caudal sections (B-F), intense hybridization is seen over cells lining the floor and infralateral walls of third ventricle and in the ARC and ME. Hybridization is absent in dorsal portions of third ventricular wall in B-E (arrows) and from the roof of third ventricle in F. {triangledown}, Denotes roof of third ventricle in B-E. DMN, dorsomedial nucleus. Original magnification x40.

 


View larger version (116K):
[in this window]
[in a new window]
 
Figure 2. High-power photomicrograph of D2 hybridization at mid- (A, B) and caudal (C, D) levels of ARC in euthyroid (A, C) and hypothyroid (B, D) animals (dark-field illumination). Note intense hybridization in floor and walls of third ventricle (III) and surrounding blood vessels in ARC, particularly in the hypothyroid animal, and at the base of hypothalamus over the tuberoinfundibular sulci (arrowheads). Long arrows denote hybridization associated with blood vessels in ARC. Original magnification x100.

 
D2 hybridization was also strikingly apparent in the ARC, particularly in hypothyroid animals, where it encircled blood vessels (Figs. 1Go, E and F and 2). Numerous instances of longitudinally oriented blood vessels and their branches completely outlined by silver grains were found throughout the ARC but were most apparent in the most caudal portions of the nucleus (Figs. 1Go, E and F and 2, C and D). Sections counterstained with hematoxylin and eosin confirmed the association of silver grains with blood vessels in the ARC and suggested its location beneath the endothelial layer (Fig. 3Go). Hybridization was also present in high density at the base of the brain at the infero-medial border of the ARC, where it formed a band at the lateral margins of the ME (Figs. 1Go, B-E and 2) overlying a cell-clear zone above the tuberoinfundibular sulci (Fig. 3Go). D2 mRNA also was seen in the substance of the ME and stalk adjacent to the portal capillaries (Fig. 1Go, B-E). No hybridization was seen in other circumventricular organs in the forebrain including the organum vasculosum of the lamina terminalis (OVLT), subfornical organ (SFO), and choroid plexus (Fig. 4AGo). In addition, little or no hybridization was seen in other hypothalamic nuclei including the PVN, where silver grains above background were conspicuously absent (Fig. 4BGo).



View larger version (129K):
[in this window]
[in a new window]
 
Figure 3. Bright-field photomicrograph showing silver grain accumulation over a blood vessel (arrow) in ARC and in a cell-clear zone overlying tuberoinfundibular sulcus (arrowheads). Original magnification x400.

 


View larger version (70K):
[in this window]
[in a new window]
 
Figure 4. In situ hybridization autoradiograms (dark-field illumination) showing absence of hybridization for D2 mRNA in SFO and choroid plexus (CP) (A) and hypothalamic PVN in hypothyroid animals (B). F, Fimbria of fornix; III, third ventricle. Original magnification x100.

 
Within the AP, distinct hybridization was present in cells primarily in the midregions of the gland (Fig. 5AGo). A marked increase in the extent of hybridization in the AP including the number of identifiable cells and hybridization density per cell was seen in the hypothyroid animals (Fig. 5BGo). Weak hybridization was occasionally found focally in the pars tuberalis in hypothyroid animals (Fig. 1DGo), although no hybridization was identified in the intermediate lobe in any animal group. The neural lobe accumulated silver grains in a small, triangular region in its most dorsolateral portions in hypothyroid animals (Fig. 5BGo), but was otherwise without hybridization. No hybridization was seen in the hypothalamus or pituitary when sense probe to D2 was used (Figs. 5CGo and 6Go).



View larger version (71K):
[in this window]
[in a new window]
 
Figure 5. Dark-field illumination of pituitary gland showing hybridization for D2 mRNA in euthyroid (A) and hypothyroid (B) animals. Note marked increase in hybridization in AP in hypothyroid animal. No hybridization is seen in intermediate lobe (IL). A small focus of hybridization (arrowhead) is present at dorso-lateral margin of NL. C, Absence of hybridization when D2 sense probe is used. Original magnification x40.

 


View larger version (85K):
[in this window]
[in a new window]
 
Figure 6. Absence of hybridization in ependymal cells lining wall of third ventricle (III), in ARC and ME when a D2 sense probe was used for in situ hybridization histochemistry. Original magnification x100.

 
To further establish the authenticity of D2 mRNA identified in the basal hypothalamus by in situ hybridization and to better quantitate the effects of hypothyroidism on D2 mRNA expression, we studied specific tissue fragments by Northern and competitive PCR analyses. In agreement with the in situ results, D2 mRNA expression analysis was high in pooled fragments of the ARC-ME from euthyroid rats and revealed a band of about 7.5 kb identical to that in the AP (Fig. 7Go). Using a competitive PCR technique, a marked increase in D2 mRNA was observed in the AP of hypothyroid rats (Fig. 8Go). In addition, the D2/Cyc mRNA ratios were higher in ARC-ME than in AP from euthyroid rats (Fig. 8Go and Table 1Go). However, in contrast to the marked increase in D2 mRNA in AP in hypothyroid rats, there was only a 1.3-fold increase of the D2/Cyc mRNA ratio in the ARC-ME (Table 1Go). D2 expression in ARC-ME and pituitary were at least 5-fold higher than in NL or in the RH from which the ARC-ME had been removed (Table 1Go). We repeated the PCR analysis in another group of three hypothyroid and euthyroid rats to confirm these results. There was a similar modest increase in the D2/Cyc mRNA ratio in ARC-ME from 0.08 ± 0.021 to 0.13 ± 0.007 (mean ± SD, Table 2Go) in hypothyroid rats. D2 mRNA expression in LH and CC in these rats was less than 20% that in ARC-ME, and D2 mRNA was not detectable in the PVN (Table 2Go).



View larger version (34K):
[in this window]
[in a new window]
 
Figure 7. Northern blot of 30 µg of total RNA from pooled anterior pituitaries (lane 1) and ARC-ME from seven euthyroid rats (lane 2). Blots were hybridized with rat D2 cDNA as described and exposed to film for 7 days. Equivalency of loading and transfer was monitored by ethidium bromide staining of 28 and 18S RNA and molecular weight markers. Positions of molecular weight markers (kb) are marked.

 


View larger version (48K):
[in this window]
[in a new window]
 
Figure 8. Quantitative PCR for rat D2 and Cyc mRNAs. A, Schematic diagram of expected sizes of wild-type and mutant PCR products of rat D2 and Cyc cDNAs used for competitive PCR. Arrows, Sense and antisense primers. Hatched box, Deleted BsaAI fragment in D2 and deleted NcoI fragment in Cyc. B, Radioautograph of standard curves and result of quantitative PCR of AP D2 and Cyc mRNAs from control (lanes 1 and 2), hypothyroid (3 and 4), and hyperthyroid (5 and 6) rats. After RT reaction using RNA from two pituitary glands in a volume of 20 µl, 4 µl of each reaction product were amplified in presence of mutant D2 or Cyc cDNA as described in Materials and Methods. Following PCR, samples were pooled to allow visualization of wild-type (w) and mutant (m) bands on same polyacrylamide gel. Note marked increase in w/m ratio of D2 in hypothyroid samples in lanes 3 and 4 but no significant differences between euthyroid and hyperthyroid samples.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Relative expression and effects of alterations in thyroid status on D2 mRNA in AP, NL, ARC-ME, and RH

 

View this table:
[in this window]
[in a new window]
 
Table 2. Comparison of D2 mRNA expression in ARC-ME, PVN, LH, and CC from euthyroid and hypothyroid rats

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
These data demonstrate that D2 mRNA is highly concentrated in a discrete region of the hypothalamus, and suggest its content in this region is partly thyroid hormone dependent. Using in situ hybridization histochemistry with a probe complementary to the coding sequence of rD2 mRNA (7), we have shown that D2 transcripts are localized exclusively to a region in the hypothalamus bounded by the rostral and caudal limits of the ME. This observation is in keeping with previous studies in which D2 activity in tissue punches from hypothyroid rats that included the ME and adjacent ARC exceeded by a factor of 10 that in any other region of the CNS (6). In euthyroid rats, the only region of CNS in which D2 activity in punch biopsies was sufficient for accurate quantitation was a ME sample that included a portion of the third ventricle but excluded the ARC. The association of silver grains in the in situ hybridization autoradiograms in the floor and discrete portions of the ependymal cells lining the lateral walls of the third ventricle, surrounding blood vessels in the ARC and adjacent to portal capillaries in the ME and organized in a cell-clear zone overlying the tuberoinfundibular sulcus, strongly suggests that this material is contained within tanycytes. Thus, the D2 activity measured in the earlier punch biopsies is synthesized in these ependymal cells, not in hypothalamic neurons as was previously supposed.

Tanycytes reside in the floor and lateral walls of the third ventricle and are distinguished from the more common mural ependymal cells by extending long, basal, cytoplasmic processes or tails into the adjacent neuropil of the medial hypothalamus and ME where they are intimately associated with capillaries and axon terminals (14, 15, 16). Similar to the distribution of D2 mRNA observed in our study in the floor and walls of the third ventricle, tanycytes tend to concentrate heavily within the lateral one third of the ependymal lining in the floor of the third ventricle, particularly in caudal portions of the ME, and are most numerous in the infralateral walls of the third ventricle (15). The abrupt termination of hybridization signal for D2 mRNA within the dorsal limits of the tuberal portion of the third ventricle and absence of hybridization from the roof of the infundibular recess is likely due to the paucity of tanycytes in this region (17). Nevertheless, the absence of hybridization in other regions of the third ventricle rostral to the ME and in other circumventricular organs lining the third ventricle including the SFO and OVLT where tanycytes are also present (14), indicate that the D2 tanycytes comprise a subpopulation of these specialized glial cells. This observation would be in keeping with the recognition that tanycytes are not a homogeneous population of cells but rather are made up of multiple different cell types based on their morphological features (14, 15, 16), immunostaining or histochemical characteristics (18, 19, 20), and response to physiological stimuli (21, 22, 23).

Although we cannot exclude the possibility that cellular components of blood vessels in the ARC express D2 transcripts, the appearance of silver grains in the autoradiograms as cuffs around ARC blood vessels is typical for tanycyte end processes. Tanycytes located in the lateral walls of the third ventricle frequently direct their distal processes toward capillary walls of blood vessels where they form loops, end feet, and networks around these vessels (14, 15, 16). The presence of organelles crowded throughout the cytoplasmic extensions of tanycytes including ribosomes, cisternae, and mitochondria (15) would explain the appearance of D2 mRNA in this location despite being at considerable distance from its cell body in the third ventricular wall. In a similar fashion, D2 mRNA present in the ME and overlying the tuberoinfundibular sulci at the lateral margins of the ME is also likely derived from tanycytes located in the floor and immediately adjacent infralateral walls of the third ventricle. These tanycytes direct cytoplasmic extensions either directly into the substance of the ME or send arching processes from the infralateral walls of the third ventricle through the ARC to end in flattened processes, juxtaposed to the basement membrane of the portal capillaries, or near the pial wall lateral to the ME (14, 15, 16).

Despite excellent morphological descriptions of tanycytes, their physiological roles are still poorly understood. Although originally believed to serve as part of the blood-brain barrier, preventing material in the perivascular spaces in the ME from leaking into the adjacent ARC or the cerebrospinal fluid (CSF) and to restrict movement of blood-borne molecules traversing the ARC from entering the ME (24, 25), it is now believed that tanycytes have much more complicated functions and likely have an active role in endocrine regulation (26). For example, tanycytes show morphological changes during the estrous cycle in the rat that include alterations in the spatial relationship between its end feet processes and LHRH axon terminals in the ME (23, 27). It has been proposed that by encasing LHRH axon terminals in the external zone of the ME, tanycyte end processes are able to restrict access of LHRH to the fenestrated capillaries of the portal capillary system for conveyance to AP gonadotrophs (27). Tanycytes may also be involved in degrading LHRH secreted from axon terminals (27a).

The fact that tanycytes are in direct contact with the CSF and have large, villous-like specializations on their apical surface that project into the third ventricular cavity (15), indicate that these cells may be capable of extracting substances from the CSF by an absorptive process. Indeed, horseradish peroxidase and ferritin injected into the CSF are taken up by tanycytes (28, 29, 30). Similar observations have been made for [3H]dopamine (31). In addition, protrusions at the apical surface of tanycytes can at times be seen to be connected to the surface of these cells by a narrow pedicle, suggesting that tanycytes release substances into the CSF (17). Thus, tanycytes may be capable of creating a cytoplasmic conduit between the CSF and the vascular system allowing the movement of substances from one compartment to the other.

On the basis of the above, we propose that the high concentrations of D2 in tanycytes lining the floor and infralateral walls of the third ventricle serve an important function by providing T3 to the CNS extracellular compartments after the uptake of T4 from the CSF. The CSF contains both free T4 and T3 in concentrations that are equal to or exceed that in the bloodstream (32, 33, 34, 35). There is evidence that the choroid plexus has an important role in the delivery of T4 to the CSF mediated by transthyretin, a T4 binding protein synthesized by choroid epithelium in abundance and secreted into the ventricles to comprise approximately 20% of the total CSF protein content (36, 37, 38, 39). However, T4 does not undergo deiodination in the choroid epithelium (40) consistent with the absence of D2 mRNA in this tissue in our study. This indicates that after T4 enters the CSF from the choroid plexus, its conversion to T3 depends on the presence of D2 at another locus in the brain. Because tanycytes envelop blood vessels in the ARC and ME, they may also be capable of extracting T4 from the systemic circulation, providing an alternative source of T3 in the CSF.

The delivery of CSF T3 to the extracellular compartment in the brain may be an important mechanism to provide adequate thyroid hormone to regions of the brain where there is little endogenous D2 activity. One of these regions is the hypothalamic PVN, which is devoid of D2 mRNA (Fig. 4Go and Table 2Go). The PVN contains hypophysiotropic TRH neurons of the hypothalamic tuberoinfundibular system (41) and thereby is an essential locus for feedback regulation by thyroid hormone to control the biosynthesis of TRH under varying physiologic states. Previous studies demonstrated that feedback regulation of TRH gene expression in paraventricular neurons is dependent on circulating levels of both T4 and T3, because approximately 1.6 times the euthyroid levels of T3 are required to restore mRNA levels back to normal in these neurons in hypothyroid animals receiving only T3 replacement (9). Because these neurons do not express D2 mRNA, they are probably incapable of converting T4 to T3 intracellularly. Thus, we have proposed that monodeiodination of T4 to T3 must occur at a separate locus within the brain and then be transported to the PVN (9, 42). The results of the present study suggest that tanycytes may provide the additional T3 required for regulation of TRH biosynthesis.

Although D2 mRNA in the ARC-ME region was modestly elevated in hypothyroid animals by quantitative reverse transcription PCR, the change in the D2/Cyc mRNA ratio was not statistically significant. Nevertheless, by in situ hybridization histochemistry, differences between the two groups were apparent particularly in the wall of the third ventricle and surrounding blood vessels in the ARC. This data might suggest that D2 mRNA in this region is at least partly regulated by thyroid hormone, consistent with previous studies showing the presence of thyroid hormone receptors in glial cells as well as neurons in the CNS (43), although the presence of thyroid hormone receptors in tanycytes has not been studied. Because D2 mRNA was also highly concentrated in a region dorsal to the tuberoinfundibular sulci, similarly in euthyroid and hypothyroid groups, inclusion of this area in the samples for PCR analysis may have diminished the ability to detect changes in D2 mRNA in hypothyroid animals by this technique. There was a marked contrast, however, between the modest or absent increase in the ARC-ME region and CC and the 11-fold increase in D2 mRNA in the AP of hypothyroid rats. The earlier studies showed that there were comparable 4-fold increases in D2 activity in both the ARC-ME and AP, but the final D2 activities per milligram protein were 4-fold higher in AP than in the ARC-ME (6). These results are consistent with those reported recently in which D2 mRNA increased much more in pituitary than in CNS, suggesting that a significant component of the up-regulation of D2 activity in the CNS and tanycytes is posttranslational (7, 44). The changes in the in situ D2 mRNA expression pattern in pituitary suggest focal increases in groups of cells with high D2 mRNA expression rather than a generalized increase in D2 mRNA in all cells (Fig. 5Go). This raises the possibility that there is an increase in the number of cells with high D2 mRNA expression in the AP in hypothyroidism, perhaps in thyrotrophs per se (45).

In conclusion, we demonstrated that D2 mRNA is highly concentrated in the hypothalamus in a distribution suggesting expression in tanycytes. Given their close proximity to the CSF and links to the vascular system in the ARC-ME through cytoplasmic extensions, we hypothesize that these cells may play an important role in the conversion of T4 to T3 and delivery of T3 locally to the CSF and the hypothalamus. By volume transmission (46), T3 would have access to extracellular spaces in the brain where it could mediate actions directly on cells involved in the regulation of TSH secretion. The marked increase in the expression of D2 mRNA in the AP compared with the hypothalamus in hypothyroid animals suggests tissue-specific transcriptional regulation by thyroid hormone.


    Footnotes
 
1 This work was supported by Grants NIH DK-37021 (to R.M.L.) and DK-36256 (to P.R.L.) and General Clinical Research Center Grant RR-02635. Back

2 Drs. Tu and Kim are equal first authors of this paper. Back

Received March 7, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Larsen PR 1996 Thyroid hormone transport, cellular uptake, metabolism, and molecular action. In: The Thyroid and Its Diseases. Churchill Livingstone, New York, pp 61–111
  2. Visser TJ, Kaplan MM, Leonard JL, Larsen PR 1983 Evidence for two pathways of iodothyronine 5'-deiodination in rat pituitary that differ in kinetics, propylthyiouracil sensitivity, and response to hypothyroidism. J Clin Invest 71:992–1002
  3. Crantz FR, Silva JE, Larsen PR 1982 Analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology 110:367–375[Medline]
  4. Meinhold H, Campos-Barros A, Walzog B, Kohler R, Muller F, Behne D 1993 Effects of selenium and iodine deficiency on type I, type II and type III iodothyronine deiodinases and circulating thyroid hormones in the rat. Exp Clin Endocrinol 101:87–93[Medline]
  5. Leonard JL, Kaplan MM, Visser TJ, Silva JE, Larsen PR 1981 Cerebral cortex responds rapidly to thyroid hormones. Science 214:571–573[Abstract/Free Full Text]
  6. Riskind PN, Kolodny JM, Larsen PR 1987 The regional hypothalamic distribution of type II 5'-monodeiodinase in euthyroid and hypothyroid rats. Brain Res 420:194–198[CrossRef][Medline]
  7. Croteau W, Davey JC, Galton VA, St. Germain DL 1996 Cloning of the mammalian type II iodothyronine deiodinase: a selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98:405–417[Medline]
  8. Salvatore D, Bartha T, Harney JW, Larsen PR 1996 Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 137:3308–3315[Abstract]
  9. Kakucska I, Rand W, Lechan RM 1992 Thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is dependent upon feedback regulation by both triiodothyronine and thyroxine. Endocrinology 130:2845–2850[Abstract]
  10. Lechan RM, Wu P, Jackson IMD, Wolfe H, Cooperman S, Mandel G, Goodman RH 1986 Thyrotropin-releasing hormone precursor: characterization in rat brain. Science 231:159–161[Abstract/Free Full Text]
  11. Chomczynski P 1995 Single-step isolation of RNA from cultured cells or tissues. In: Ausubel FM, Brent B, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds.) Current Protocols in Molecular Biology. Wiley Interscience, New York, vol 1:4.2.4–4.2.8
  12. Danielson PE, Forss-Petter S, Brow MA, Calavetta L, Douglass J, Milner RJ, Sutcliffe JG 1988 p1B15:a cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261–267[Medline]
  13. Zhao J, Araki N, Nishimoto SK 1995 Quantitation of matrix Gla protein mRNA by competitive polymerase chain reaction using glyceraldehyde-3-phosphate dehydrogenase as an internal control. Gene 155:159–165[CrossRef][Medline]
  14. Blier R 1972 Structural relationship of ependymal cells and their processes within the hypothalamus. In: Knigge KM, Scott DE, Weindl A (eds) Brain-Endocrine Interaction. Median Eminence: Structure and Function. Karger, Basel, pp 306–318
  15. Bruni JE 1974 Scanning and transmission electron microscopy of the ependymal lining of the third ventricle. J Can Sci Neurol 1:59–73.
  16. Rodriguez EM, Gonzalez CB, Delannoy L 1979 Cellular organization of the lateral and postinfundibular regions of the median eminence in the rat. Cell Tissue Res 201:377–408[Medline]
  17. Mitro A, Palkovits M 1981 Morphology of the rat brain ventricle, ependyma, and periventricular structures. Bibl Anat 21:1–110
  18. Akmayev IF, Fidelina OV 1976 Morphological aspects of the hypothalamic-hypophyseal system. VI. The tanycytes: their relation to the sexual differentiation of the hypothalamus. An enzyme-histochemical study. Cell Tissue Res 173:407–416[Medline]
  19. Luppa H, Feustel G 1971 Location and characterization of hydrolytic enzymes of the IIIrd ventricle lining in the region of the recessus infundibularis of the rat. A study on the function of the ependyma. Brain Res 29:253–270[CrossRef][Medline]
  20. Meister B, Hokfelt T, Tsuruo Y, Hemmings H, Ouimet C, Greengard P, Goldstein M 1988 DARPP-32, a dopamine- and cyclic AMP-regulated phosphoprotein in tanycytes of the mediobasal hypothalamus: distribution and relation to dopamine and luteinizing hormone-releasing hormone neurons and other glial elements. Neuroscience 27:607–622[CrossRef][Medline]
  21. Schechter J, Weiner R 1972 Ultrastructural changes in the ependymal lining of the median eminence following the intraventricular administration of catecholamine. Anat Rec 172:643–650[CrossRef][Medline]
  22. Brawer JR, Lin PS, Sonnenschein C 1974 Morphological plasticity in the wall of the third ventricle during the estrous cycle in the rat: a scanning electron microscopic study. Anat Rec 179:481–489[CrossRef][Medline]
  23. King JC, Letourneau RJ 1994 Luteinizing hormone-releasing hormone terminals in the median eminence of rats undergo dramatic changes after gonadectomy, as revealed by electron microscopic image analysis. Endocrinology 134:1340–1351[Abstract]
  24. Krisch B, Leonhardt H 1978 The functional and structural border of the neurohemal region of the median eminence. Cell Tissue Res 192:327–339[Medline]
  25. Rethelyi M, Fockter V 1982 The fiber architecture of the rat median eminence with some accidental observations on the significance of tanycyte processes. Acta Biol Acad Sci Hung 33:289–300
  26. Garcia-Segura LM, Chowen JA, Naftolin F 1996 Endocrine glia: roles of glial cells in the brain actions of steroid and thyroid hormones and in the regulation of hormone secretion. Front Neuroendocrinol 17:180–211[CrossRef][Medline]
  27. King JC, Rubin BS 1994 Dynamic changes in LHRH neurovascular terminals with various endocrine conditions in adults. Horm Behav 28:349–356[CrossRef][Medline]
  28. Wu TJ, Pierotti AR, Jakubowski M, Sheward WJ, Glucksman MJ, Smith AI, King JC, Fink G, Roberts JLEndopeptidase EC 3.4.24.15 presence in the rat median eminence and hypophysial portal blood, and its modulation of the luteinizing hormone surge. J Neuroendocrinol, in press
  29. Kobayashi H, Wada M, Uemura H 1972 Uptake of peroxidase from the third ventricle by ependymal cells of the median eminence. Z Zellforsch 127:545–551[CrossRef][Medline]
  30. Nakai Y, Naito N 1975 Uptake and bidirectional transport of peroxidase injected into the blood and cerebrospinal fluid by ependymal cells of the median eminence. In: Knigge KM, Scott DE, Kobayashi H, Ishii S (eds) Brain-Endocrine Interaction II. The Ventricular System. Karger, Basel, pp 94–108
  31. Ugrumov MV, Mitskevich MS 1980 The adsorptive and transport capacity of tanycytes during the perinatal peroid of the rat. Cell Tissue Res 211:493–501[Medline]
  32. Ugrumov MV, Mitskevich MS, Arluison M, Tramu G 1986 Ependymal lining of the infundibular recess in perinatal rats: relationships with portal capillaries and permeability. Int J Dev Neurosci 4:101–111[CrossRef][Medline]
  33. Hagen GA, Elliott WJ 1973 Transport of thyroid hormones in serum and cerebrospinal fluid. J Clin Endocrinol Metab 37:415–422[Medline]
  34. Nishikawa M, Inada M, Naito K, Ishii H, Tanaka K, Mashio Y, Nakao K, Nakai Y, Udaka F, Imura H 1981 3,3',5'-Triiodothyronine (reverse T3) in human cerebrospinal fluid. J Clin Endocrinol Metab 53:1030–1035[Abstract]
  35. Thompson P, Burman KD, Jr, Wright FD, Potter MW, Wartofsky L 1982 Iodothyronine levels in human cerebrospinal fluid. J Clin Endocrinol Metab 54:653–655[Abstract]
  36. Kirkegaard C, Faber J 1991 Free thyroxine and 3,3',5'-triiodothyronine levels in the cerebrospinal fluid and in patients with endogenous depression. Acta Endocrinol (Copenh) 124:166–172[Medline]
  37. Spector R, Levy P 1975 Thyroxine transport by the choroid plexus in vitro. Brain Res 98:400–404[CrossRef][Medline]
  38. Herbert J, Wilcox JN, Pham K-T C, Fremeau RT, Zeviani M, Dwork A, Soprano DR, Makover A, Goodman DS, Zimmerman EA, Roberts JL, Schon EA 1986 Transthyretin: a choroid plexus-specific transport protein in human brain. Neurology 36:900–911[Abstract/Free Full Text]
  39. Dickson PW, Aldred AR, Menting JGT, Marley PD, Sawyer WH, Schreiber G 1987 Thyroxine transport in choroid plexus. J Biol Chem 262:13907–13915[Abstract/Free Full Text]
  40. Schreiber G, Aldred AR, Jaworowski A, Nilsson C, Achen MG, Segal MB 1990 Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus. Am J Physiol 258:R338–R345
  41. Southwell BR, Duan W, Alcorn D, Brack C, Richardson SJ, Kohrle J, Schreiver G 1993 Thyroxine transport to the brain: role of protein synthesis by the choroid plexus. Endocrinology 133:2116–2126[Abstract]
  42. Lechan RM, Toni R 1992 Thyrotropin-releasing hormone neuronal systems in the central nervous system. In: Nemeroff CB (ed) Neuroendocrinology. CRC Press, Boca Raton, FL, pp 279–330
  43. Lechan RM, Kakucska I 1992 Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the hypothalamic paraventricular nucleus. Ciba Found Symp 168:144–164[Medline]
  44. Puymirat J, Miehe M, Marchand R, Sarlieve L, Dussault JH 1991 Immunohistochemical localization of thyroid hormone receptors in the adult rat brain. Thyroid 1:173–184[Medline]
  45. Leonard JL, Silva JE, Kaplan MM, Mellen SA, Visser TJ, Larsen PR 1984 Acute post-transcriptional regulation of cerebrocortical and pituitary iodothyroinine 5'-deiodinase by thyroid hormone. Endocrinology 114:998–1004[Abstract]
  46. Koenig RJ, Watson AY 1984 Enrichment of rat anterior pituitary cell types by metrizamide density gradient centrifugation. Endocrinology 115:314–323
  47. Agnati LF, Zoli M, Stromberg I, Fuxe K 1995 Intercellular communication in the brain: wiring vs. volume transmission. Neuroscience 69:711–726[CrossRef][Medline]



This article has been cited by other articles:


Home page
EndocrinologyHome page
E. Sanchez, P. S. Singru, C. Fekete, and R. M. Lechan
Induction of Type 2 Iodothyronine Deiodinase in the Mediobasal Hypothalamus by Bacterial Lipopolysaccharide: Role of Corticosterone
Endocrinology, May 1, 2008; 149(5): 2484 - 2493.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Fekete, B. C. G. Freitas, A. Zeold, G. Wittmann, A. Kadar, Z. Liposits, M. A. Christoffolete, P. Singru, R. M. Lechan, A. C. Bianco, et al.
Expression Patterns of WSB-1 and USP-33 Underlie Cell-Specific Posttranslational Control of Type 2 Deiodinase in the Rat Brain
Endocrinology, October 1, 2007; 148(10): 4865 - 4874.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Yasuo, T. Yoshimura, S. Ebihara, and H.-W. Korf
Temporal Dynamics of Type 2 Deiodinase Expression after Melatonin Injections in Syrian Hamsters
Endocrinology, September 1, 2007; 148(9): 4385 - 4392.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S. M. Wajner, M. dos Santos Wagner, R. C N Melo, G. G Parreira, H. Chiarini-Garcia, A. C Bianco, C. Fekete, E. Sanchez, R. M Lechan, and A. L. Maia
Type 2 iodothyronine deiodinase is highly expressed in germ cells of adult rat testis
J. Endocrinol., July 1, 2007; 194(1): 47 - 54.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Yasuo, M. Watanabe, M. Iigo, T. J. Nakamura, T. Watanabe, T. Takagi, H. Ono, S. Ebihara, and T. Yoshimura
Differential response of type 2 deiodinase gene expression to photoperiod between photoperiodic Fischer 344 and nonphotoperiodic Wistar rats
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1315 - R1319.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. G. Revel, M. Saboureau, P. Pevet, J. D. Mikkelsen, and V. Simonneaux
Melatonin Regulates Type 2 Deiodinase Gene Expression in the Syrian Hamster
Endocrinology, October 1, 2006; 147(10): 4680 - 4687.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Zeold, M. Doleschall, M. C. Haffner, L. P. Capelo, J. Menyhert, Z. Liposits, W. S. da Silva, A. C. Bianco, I. Kacskovics, C. Fekete, et al.
Characterization of the Nuclear Factor-{kappa}B Responsiveness of the Human dio2 Gene
Endocrinology, September 1, 2006; 147(9): 4419 - 4429.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A. Alkemade, E. C Friesema, G. G Kuiper, W. M Wiersinga, D. F Swaab, T. J Visser, and E. Fliers
Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary.
Eur. J. Endocrinol., March 1, 2006; 154(3): 491 - 500.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. del Barco Barrantes, A. Montero-Pedrazuela, A. Guadano-Ferraz, M.-J. Obregon, R. Martinez de Mena, V. Gailus-Durner, H. Fuchs, T. J. Franz, S. Kalaydjiev, M. Klempt, et al.
Generation and Characterization of dickkopf3 Mutant Mice.
Mol. Cell. Biol., March 1, 2006; 26(6): 2317 - 2326.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont
Selenium, the Thyroid, and the Endocrine System
Endocr. Rev., December 1, 2005; 26(7): 944 - 984.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Y Chan, M. H Andrews, R. Lingas, C. J McCabe, J. A Franklyn, M. D Kilby, and S. G Matthews
Maternal nutrient deprivation induces sex-specific changes in thyroid hormone receptor and deiodinase expression in the fetal guinea pig brain
J. Physiol., July 15, 2005; 566(2): 467 - 480.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Alkemade, E. C. Friesema, U. A. Unmehopa, B. O. Fabriek, G. G. Kuiper, J. L. Leonard, W. M. Wiersinga, D. F. Swaab, T. J. Visser, and E. Fliers
Neuroanatomical Pathways for Thyroid Hormone Feedback in the Human Hypothalamus
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4322 - 4334.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Coppola, R. Meli, and S. Diano
Inverse Shift in Circulating Corticosterone and Leptin Levels Elevates Hypothalamic Deiodinase Type 2 in Fasted Rats
Endocrinology, June 1, 2005; 146(6): 2827 - 2833.
[Abstract] [Full Text] [PDF]